Apimeds Pharmaceuticals US (APUS) Interest Expenses (2024 - 2025)
Apimeds Pharmaceuticals US (APUS) reported Interest Expenses of $215624.0 for Q4 2025, up 498.12% on a YoY basis from $36050.0 in Q4 2024, and up 3322.06% quarter-over-quarter from $6301.0 in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Interest Expenses (2024 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US has reported Interest Expenses for 2 years, with the latest figure at $215624.0 in Q4 2025.
- For the quarter ending Q4 2025, Interest Expenses rose 498.12% year-over-year to $215624.0; the trailing twelve-month figure through Dec 2025 stood at $283011.0 (up 140.41% YoY), and the FY2025 full-year result was $283011.0, up 140.41% from the prior year.
- Interest Expenses for Q4 2025 stood at $215624.0, up from $6301.0 in the prior quarter.
- The five-year high for Interest Expenses was $215624.0 in Q4 2025, with the low at $6301.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.00 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 20.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 4.86 Mn |
| 10 | Apimeds Pharmaceuticals US | 13.93 Mn | 10.29 Mn | - | 215,624.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 215,624.00 |
| Dec 31, 2025 | 215,624.00 |
| Sep 30, 2025 | 6,301.00 |
| Sep 30, 2025 | 6,301.00 |
| Jun 30, 2025 | 23,054.00 |
| Jun 30, 2025 | 23,054.00 |
| Mar 31, 2025 | 38,032.00 |
| Mar 31, 2025 | 38,032.00 |
| Dec 31, 2024 | 36,050.00 |
| Dec 31, 2024 | 36,050.00 |
| Sep 30, 2024 | 32,638.00 |
| Sep 30, 2024 | 32,638.00 |
| Jun 30, 2024 | 22,123.00 |
| Jun 30, 2024 | 22,123.00 |
| Mar 31, 2024 | 26,908.00 |
| Mar 31, 2024 | 26,908.00 |